Molecular NeurobiologyNeurosciencePeer-reviewed journal article
Fibroblast growth factor 9 stimulates neurite outgrowth through NF-kB signaling in striatal cell Huntington's disease models
Issa Olakunle YusufiD, Hsiu-Mei Chen, Pei‐Hsun Cheng, C.S. Chang, Shaw‐Jenq TsaiiD, Jih‐Ing ChuangiD, Chia‐Ching WuiD, Bu‐Miin HuangiD, H. Sunny SuniD, Chuan‐Mu CheniD, Shang‐Hsun YangiD
Abstract
Proper development of neuronal cells is important for brain functions, and impairment of neuronal development may lead to neuronal disorders, implying that improvement in neuronal development may be a therapeutic direction for these diseases. Huntingtons disease (HD) is a neurodegenerative disease characterized by impairment of neuronal structures, ultimately leading to neuronal death and dysfunctions of the central nervous system. Based on previous studies, fibroblast growth factor 9 (FGF9) may provide neuroprotective functions in HD, and FGFs may enhance neuronal development and neurite outgrowth. However, whether FGF9 can provide neuronal protective functions through improvement of neuronal morphology in HD is still unclear. Here, we study the effects of FGF9 on neuronal morphology in HD and attempt to understand the related working mechanisms. Taking advantage of striatal cell lines from HD knock-in mice, we found that FGF9 increases neurite outgrowth and upregulates several structural and synaptic proteins under HD conditions. In addition, activation of nuclear factor kappa B (NF-kB) signaling by FGF9 was observed to be significant in HD cells, and blockage of NF-kB leads to suppression of these structural and synaptic proteins induced by FGF9, suggesting the involvement of NF-kB signaling in these effects of FGF9. Taken these results together, FGF9 may enhance neurite outgrowth through upregulation of NF-kB signaling, and this mechanism could serve as an important mechanism for neuroprotective functions of FGF9 in HD.
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: cell-cell communication
- approach: experimental assay
- Citations
- 20
- FWCI
- 1.27
- Field percentile
- top 25%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neuroprotective effects of hepatoma-derived growth factor in models of Huntington's disease
Kerstin Voelkl, Sara Gutiérrez-Ángel, … Irina Dudanova·Life Science AlliancePeer-reviewed·Aug 14, 2023
- Striatal neuron excitability is regulated by huntingtin in the adult brain
Jessica C. Barron, Meghan L. Greenland, … Matthew P. Parsons·eNeuroPeer-reviewed·May 28, 2026
- Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates
Paula García-Huerta, Paulina Troncoso-Escudero, … Claudio A. Hetz·Acta NeuropathologicaPeer-reviewed·Jul 8, 2020
- In vivo progressive degeneration of Huntington's disease patient-derived neurons reveals human-specific pathological phenotypes
Andrés Miguez, Sara Fernández‐García, … Josep Maria Canals·bioRxiv·Oct 21, 2020
- Protective role of Pten downregulation in Huntington's Disease models
Nisha Nisha, Deepti Thapliyal, … Mayanglambam Dhruba Singh·bioRxiv·Mar 28, 2024
- Screening of a kinase inhibitor library in human Huntington disease iPSC derived striatal precursor neurons reveals a neuroprotective effect of PKC alpha and PKC beta1 inhibition
Mali Jiang, Tianze Shi, … Christopher A. Ross·bioRxiv·Sep 18, 2025